Epithalon 50mg

Source: https://pubmed.ncbi.nlm.nih.gov/12937682/

Scientific Findings

This foundational study from the St. Petersburg Institute of Bioregulation and Gerontology examined whether Epithalon could activate telomerase in human cells that had naturally silenced it — which is the case in most adult body cells. Using human fetal fibroblast cultures that tested negative for telomerase activity, researchers added Epithalon to the cell culture medium and measured the results. The treatment induced expression of the catalytic subunit of telomerase, triggered measurable telomerase enzyme activity, and produced elongation of the telomeres — the protective caps at the ends of the chromosomes. The authors concluded that this reactivation of the telomerase gene in somatic cells points to the possibility of extending the lifespan of cell populations, and potentially of the whole organism.

Plain English Summary

This is the landmark Epithalon study that sparked decades of follow-up research. In plain terms, it showed that Epithalon could switch on an enzyme — telomerase — that normal adult cells have switched off. Telomerase is what allows cells to rebuild the protective tips of their chromosomes after each division. Without it, those tips get shorter and shorter until cells stop dividing entirely — one of the most fundamental processes in biological aging. The fact that Epithalon reactivated this enzyme in cells that had lost it made it one of the most discussed anti-aging research compounds of the past two decades.

Source: https://pubmed.ncbi.nlm.nih.gov/15027858/

Scientific Findings

Building directly on the 2003 telomerase study, this follow-up research examined what telomerase reactivation actually meant for how long cells could survive and divide. Human fetal fibroblast cells from a 24-week fetus naturally stopped dividing after the 34th passage — their built-in division limit, known as the Hayflick limit. At that point, telomere length had declined measurably compared to early passages. When Epithalon was added to these aging cell cultures, it restored telomere length to sizes comparable to early-passage cells. The treated cells then continued dividing for 10 additional passages — reaching the 44th passage and continuing — compared to controls that had already stopped. The researchers concluded that Epithalon prolonged the vital cycle of normal human cells by overcoming the Hayflick limit through telomere elongation.

Plain English Summary

Every human cell has a built-in limit on how many times it can divide before it permanently stops — a biological clock called the Hayflick limit. This study showed that Epithalon-treated cells blew past that limit, dividing 10 more times than untreated cells that had already reached their endpoint. The mechanism was the telomere restoration seen in the previous study — once the protective chromosome caps were rebuilt to their earlier length, the cells essentially reset their division counter. In research terms, this is one of the most concrete demonstrations of Epithalon's potential relevance to cellular longevity science.

Source: https://pubmed.ncbi.nlm.nih.gov/12360351/

Scientific Findings

This in vivo study examined whether Epithalon could reduce the accumulation of chromosomal damage — a key hallmark of biological aging — in living animals. Three mouse groups were used: SAMP-1 mice with accelerated aging, wild-type SAMR-1 mice, and SHR mice. By 12 months of age, bone marrow cells in the SAMP-1 accelerated-aging mice showed chromosomal aberration rates 1.8 to 2.2 times higher than the other strains. Epithalon treatment beginning at 2 months of age significantly reduced chromosomal aberrations across all three groups — by 20% in SAMP-1 mice, 30.1% in SAMR-1 mice, and 17.9% in SHR mice compared to age-matched controls. Melatonin treatment used as a comparison showed no effect on chromosomal aberration rates in SHR mice. The researchers concluded that Epithalon exerts an antimutagenic effect that likely underlies its broader geroprotective properties.

Plain English Summary

As cells age, their chromosomes accumulate errors and damage — a process that contributes directly to age-related disease and cellular decline. This study found that Epithalon consistently reduced that chromosomal damage across multiple mouse strains — including both normal aging and accelerated aging models — by up to 30%. Importantly, melatonin — the hormone most closely associated with the pineal gland, where Epithalon originates — had no effect in the same test. This suggests Epithalon's protective effect on DNA is independent of melatonin and may represent a distinct mechanism of genomic protection that researchers continue to investigate in the context of aging biology.